148 related articles for article (PubMed ID: 32958145)
21. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
22. Expression of the glutamine metabolism-related proteins glutaminase 1 and glutamate dehydrogenase in canine mammary tumours.
Ryu JE; Park HK; Choi HJ; Lee HB; Lee HJ; Lee H; Yu ES; Son WC
Vet Comp Oncol; 2018 Jun; 16(2):239-245. PubMed ID: 29266697
[TBL] [Abstract][Full Text] [Related]
23. Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours.
Raposo TP; Pires I; Carvalho MI; Prada J; Argyle DJ; Queiroga FL
Vet Comp Oncol; 2015 Dec; 13(4):464-74. PubMed ID: 24119241
[TBL] [Abstract][Full Text] [Related]
24. Expression of Tumour Endothelial Marker 8 in Canine Mammary Gland Tumour Cells.
Noguchi S; Araki M; Nakajima K; Koh M; Kokado Y; Kubo Y; Otsuka H; Yasuda A; Yokosuka M; Soeta S
J Comp Pathol; 2019 Nov; 173():30-40. PubMed ID: 31812171
[TBL] [Abstract][Full Text] [Related]
25. Tumour-associated macrophages: Relation with progression and invasiveness, and assessment of M1/M2 macrophages in canine mammary tumours.
Monteiro LN; Rodrigues MA; Gomes DA; Salgado BS; Cassali GD
Vet J; 2018 Apr; 234():119-125. PubMed ID: 29680383
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
Amorim I; Lopes CC; Faustino AM; Pereira PD
J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
[TBL] [Abstract][Full Text] [Related]
27. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer.
Queiroga FL; Pires I; Parente M; Gregório H; Lopes CS
Vet J; 2011 Jul; 189(1):77-82. PubMed ID: 20675158
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Hypoxia-Inducible Factor-1α Expression Relative to Other Key Factors in Malignant Canine Mammary Tumours.
Shin JI; Lim HY; Kim HW; Seung BJ; Sur JH
J Comp Pathol; 2015; 153(2-3):101-10. PubMed ID: 26145724
[TBL] [Abstract][Full Text] [Related]
30. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
Millanta F; Caneschi V; Ressel L; Citi S; Poli A
J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
[TBL] [Abstract][Full Text] [Related]
31. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
[TBL] [Abstract][Full Text] [Related]
32. Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats.
Beha G; Muscatello LV; Brunetti B; Asproni P; Millanta F; Poli A; Benazzi C; Sarli G
J Comp Pathol; 2014; 150(2-3):194-7. PubMed ID: 24060151
[TBL] [Abstract][Full Text] [Related]
33. The role of CD44 adhesion factor in canine mammary carcinomas.
Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of FOXP3 expression in canine mammary gland tumours.
Oh SY; Ryu HH; Yoo DY; Hwang IK; Kweon OK; Kim WH
Vet Comp Oncol; 2014 Mar; 12(1):20-8. PubMed ID: 22541038
[TBL] [Abstract][Full Text] [Related]
35. Studies on canine mammary tumours. II. Oestradiol and progesterone receptor binding capacity and histological type.
Boldizsár H; Muray T; Számel I; Szenci O; Csenki J
Acta Vet Hung; 1992; 40(1-2):89-97. PubMed ID: 1476094
[TBL] [Abstract][Full Text] [Related]
36. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
37. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
38. Transcriptomic profile reveals molecular events associated to focal adhesion and invasion in canine mammary gland tumour cell lines.
Cordeiro YG; Xavier PLP; Rochetti AL; Alexandre PA; Mori CMC; Strefezzi RF; Fukumasu H
Vet Comp Oncol; 2018 Mar; 16(1):E89-E98. PubMed ID: 28834169
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological significance of caspase-3 and Ki-67 expression in canine mammary gland tumours.
Rodrigues H; Carvalho MI; Pires I; Prada J; Queiroga FL
Acta Vet Hung; 2016 Mar; 64(1):78-89. PubMed ID: 26919145
[TBL] [Abstract][Full Text] [Related]
40. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]